Simplex Trading’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
WE
BCM
KAS
Simplex Trading's LPCN Position: Q4 2020 in Review
Simplex Trading sold out of Lipocine (LPCN) in Q4 2020, closing a stake of 1,561 shares — an estimated $37.6K sold.
Simplex Trading first reported a position in LPCN in Q4 2015 and held it in 15 quarters. The position peaked at $251K in Q2 2017. 33 funds tracked by Wall St. Rank hold LPCN as of Q4 2020.
- Simplex Trading reported no remaining Lipocine position as of Q4 2020 after selling out during the quarter.
- Simplex Trading sold 1,561 Lipocine shares in Q4 2020, an estimated $37.6K.
- Simplex Trading first reported a position in Lipocine in Q4 2015 and held it in 15 quarters.
- Simplex Trading's Lipocine position peaked at $251K in Q2 2017.
- 33 funds tracked by Wall St. Rank held Lipocine as of Q4 2020.
Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.